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EFFECT OF NYALURONIDASE ON SHEEP CELL AGGLUTINATION AND LATEX
FIXATION TESTS IN CONTEMPORARY SERA AND JOINT FLUIDSt
Most clinical studies involving rheumatoid factors are made on sera;
relatively few investigations are reported on rheumatoid factors in joint
fluid, connective tissue extracts, interstitial fluid and cells. Joint fluid of
patients with rheumatoid arthritis often contains rheumatoid factor,
measured by the latex fixation and sheep cell agglutination tests.,"'8
Mellors, et al.' established evidence that in patients with rheumatoid
arthritis, rheumatoid factor is synthesized by plasma cells in at least three
tissues, lymph nodes, rheumatoid nodules and synovialis. Since plasma
cells do not circulate, the rheumatoid factor molecule probably appears first
in connective tissues and moves to serum, presumably via the lymphatic
system.
Krehl, et al.' reported results of sheep cell agglutination tests on simul-
taneously collected sera and joint fluids from patients with rheumatoid
arthritis and certain other diseases. Joint fluid tests were less often positive
than serum tests, but when joint fluid was positive, it was so in higher
titer than serum. Joint fluids were examined before and after incubation
with hyaluronidase. Fluids showing positive tests before hyaluronidase
treatment did not change after incubation. However, significant numbers
of tests previously negative became positive after hyaluronidase treatment.
Except for its hyaluronic acid content joint fluid is regarded as having
the chemical composition of an ultrafiltrate of plasma; since hyaluronidase
specifically hydrolyzes hyaluronic acid, and the sheep cell agglutination
tests in joint fluid, previously negative, disclosed positive tests after
hyaluronidase treatment, Krehl, et al.' interpreted the change to positivity
as being due to some change in hyaluronic acid or a consequence of such
change. One possibility is that a protein in complex with hyaluronic acid
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in joint fluid is released to react with sensitized sheep cells, being incapable
of reaction when bound to polysaccharide.
To further test the hypothesis that treatment of sera and joint fluids
with hyaluronidase changes the result of sheep cell agglutination and latex
fixation tests, contemporary sera and joint fluids were collected from
three groups of patients and tested as outlined below.*
TABLE 1. SHEEP CELL AGGLUTINATION TEST ON SERA AND JOINT FLUIDS,
PRE- AND POST-HYALURONIDASE INCUBATION
Post in- Joint Post in-
Diagnosis Age Sex Serum cubation fluid cubation
1. Rheumatoid arthritis 52 F 1-256 1-128 1-256 1-8
2. Rheumatoid arthritis 53 F 1-64 <1-4 1-128 1-64
3. Rheumatoid arthritis 53 F 1-64 <1-4 1-64 1-64
4. Rheumatoid arthritis 52 F 1-128 <1-4 <1-8 <1-4
5. Rheumatoid arthritis 52 F 1-64 1-64 1-64 1-64
6. Rheumatoid arthritis 52 F <1-8 <1-4 1-32 <1-8
7. Rheumatoid arthritis 45 M <1-4 <1-4 <1-4 <1-4
8. Rheumatoid arthritis 65 F <1-4 <1-4 <1-4 <1-4
9. Rheumatoid arthritis 56 F <1-4 <1-4 <1-16 <1-8
10. Rheumatoid arthritis 50 F 1-128 <1-4 <1-4 <1-4
11. Polyarthritis 35 F <1-4 <1-4 <1-4 <1-4
12. Polyarthritis 37 F <1-4 <1-4 <1-4 <1-4
13. Ankylosing spondylitis 45 M <1-8 <1-4 <1-4 <1-4
14. Ankylosing spondylitis 55 F <1-4 <1-4 <1-4 <1-4
15. Ankylosing spondylitis 36 M <1-4 <1-4 <1-4 <1-4
16. Periarteritis nodosa 38 M <1-4 <1-4 <1-8 <1-4
17. Periarteritis nodosa 32 M <1-4 <1-4 <1-4 <1-4
18. Behcet's syndrome 22 M <1-4 <1-4 <1-4 <1-4
19. Reiter's disease 45 M <1-4 <1-4 <1-4 <1-4
20. Vasculitis 19 M <1-4 <1-4 <1-4 <1-4
METHODS
Sera and joint fluids were collected at the same time from three groups of patients;
Group A, rheumatic disease patients (sheep cell agglutination test used); Group B,
post mortem patients without rheumatic disease (sheep cell agglutination test used)
Group C, rheumatic disease patients (latex fixation test used).
Fluid specimens were obtained mainly from knee joints. Aspirations were done in
Groups A and C under aseptic precautions with special effort to avoid contamination
* The technique used for the sheep cell agglutination test is not strictly comparable to
that used by Krehl, et al.'; the test used (Ball modification of Rose test' has been in
continual use in one laboratory since June, 1950 and was regarded as more likely to give
meaningful results.
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with blood. Knee joints were surgically opened in post mortem subjects of Group B.
The fluids were centrifuged to remove any fibrin clot, cells, or debris and stored at
40 C. The tests were done on paired sera and joint fluids several days later. For Groups
A and B Sigma Hyalase (British) was used. It was dissolved in 0.1 molar glycerine
buffer to a final concentration of 1 mg. per ml. at pH 6.0 containing 1% NaCl;
0.5 ml. hyaluronidase solution was added to 0.1 ml. serum and joint fluid respectively
and incubated for twelve hours @ 370 C. At the same time 0.5 ml. of buffer was added
to the control 0.5 ml. aliquots of sera and joint fluids. The change in viscosity was
measured in each joint fluid. In each instance the value began to plateau five to ten
minutes after addition of hyaluronidase. After incubation the sera and joint fluids
TABLE 2. CHANGES NOTED IN SERA AND FLUIDS AFTER
HYALURONIDASE INCUBATION
Titer* Serum Joint fluid
Unchanged 15 17
Positive to negative 4 2
Negative to positive 0 0
Higher to lower titer 1 1
20 20
* Titer of 1: 32 is border-line of positive.
were placed in the refrigerator and the sheep cell agglutination test was done the next
day (Ball modification of the Rose test).'
Group C was examined in the same way except that the latex fixation test, according
to the method of Singer and Plotz7 was used; the incubation period with hyaluronidase
was five to six hours at 370 C.; pH 6.0 was used; a pH of 8.2 was tried at varying
lengths of time from one hour to 18 hours incubation at 37°; these changes in method
produced no change in results. After incubation the sera and fluids were stored in the
refrigerator and the latex test done the next day. Hyaluronidase (testicular) was
obtained from Worthington Biochemical Company. All control tests were incubated in
buffer without hyaluronidase to detect any changes occurring in storage or incubation,
and to be certain that any change observed was caused by hyaluronidase.
RESULTS AND DISCUSSION
Group A. Twenty simultaneously collected samples of sera and joint
fluids were examined by the sheep cell agglutination test.' A titer of 1-32
is considered positive. Table 1 lists the results. Table 2 depicts the
changes after hyaluronidase treatment.
Serum changes: One patient with rheumatoid arthritis had a serum titer
of 1-64 prior to and less than 1-4 after incubation; a third dropped
by the same amount; two positive sera were unchanged after incubation.
No negative tests became positive.
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Joint fluid changes: One positive fluid dropped in titer from 1-256
to less than 1-8. Two positive fluids were unchanged and one dropped
in titer from 1-32 to less than 1-8.
Group B: Table 3 lists results of examples of ten knee joint fluids
obtained post-mortem from patients having no known rheumatic disease.
No positive tests occurred.
TABLE 3. SHEEP CELL AGGLUTINATION TESTS ON SYNOVIAL FLUIDS OBTAINED
AT POST MORTEM: PRE- AND POST-INCUBATION 12 HOURS
WITH HYALURONIDASE
S.C.A.T.* S.C.A.T.
Cause of death Age Sex Hyal'ase Hyal'ase
Trauma 90 M <1-8 <1-8
(Obscure CNS disease)
Hydrocephalus 52 M <1-4 <1-4
Myocardial infarction 54 M (RT <1-8 <1-8
(RT <1-16 <1-8
Pulmonary stenosis 12 F (RT <1-16 <1-8
(LT <1-16 <1-8
Diabetes mellitus 49 F (RT <1-16 <1-4
(LT <1-4 <14
Reticulum cell leukemia 32 F <1-16 <1-8
Diverticulitis 63 F <1-16 <1-8
Temporal lobe tumor 69 M <1-8 <1-8
Bronchial carcinoma 79 M <1-8 <1-8
Carcinoma pancreas 72 M <1-4 <1-4
* Sheep cell agglutination test.
Group C: Using the latex fixation test the 43 pairs were examined
pre- and post-hyaluronidase treatment as outlined above. Table 4 lists
the diagnostic categories of the patients and Table 5 shows results of
latex fixation tests. Sixteen patients with definite or classic rheumatoid
arthritis had strongly positive latex tests before hyaluronidase treatment
in both sera and joint fluids. Nineteen tests were negative; eight were low
titer positive in serum or synovial fluid or both. After incubation with
hyaluronidase no changes occurred. Six of the pairs were re-examined pre-
and post-hyaluronidase incubation two to four times with no change in
the results.
Enzymatic treatment of sera and synovial fluid with hyaluronidase did
not alter the latex fixation test. If rheumatoid factor or some fraction
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of it were combined with hyaluronic acid in joint fluid, this manipulation
would, in all probability, denature the molecule sufficiently to change its
reactivity. It is improbable that the reacting factor is chemically combined
to hyaluronic acid. Rheumatoid factor is probably free in synovial fluid
TABLE 4. DIAGNOSIS AND SEX OF 43 PATIENTS ATTENDING
RHEUMATISM CLINICS
Diagnosis Males Females Total
Rheumatoid arthritis 11 15 26
Ankylosing spondylitis 1 1 2
Gout 1 1 2
Psoriatic arthritis 2 0 2
Osteoarthritis 2 1 3
Carcinoma & polyarthritis 1 1 2
Porphyria hepatica 1 0 1
Rheumatic fever 0 1 1
Dermatomyositis 0 1 1
Lupus erythematosus 0 2 2
Non-specific polyarthritis 1 0 1
Total 20 23 43
TABLE 5. RESULTS OF LATEX FIXATION TESTS ON 43 PATIENTS ATTENDING
RHEUMATISM CLINICS (BOTH BEFORE AND AFTER TREATMENT
WITH HYALURONIDASE)
Males Females Total
Strongly positive serum and
joint fluid 9 7 16
Negative serum and joint fluid 9 10 19
Low titer positive serum, joint
fluid or both 2 6 8
Total 20 23 43
as soluble antigen-antibody-like complex, as it exists in serum. Since
in the latex test inert particles are substituted for sheep cells, any partici-
pation of an organic cell membrane in the reaction is precluded.
The results may be interpreted as indication that rheumatoid factor
exists in the free state in the positive and low titer positive fluids and
sera and its physicochemical properties are not influenced by hyaluronidase;
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the negative tests of sera are unaltered by hyaluronidase digestion and the
hyaluronic acid-protein complex of joint fluid is digested, freeing normal
globulins with no effect on the titer of the test.
SUMMARY
1. To determine if there is a relationship between rheumatoid factor
and protein-hyaluronic acid complex of joint fluid, three groups of sera
and joint fluids were collected simultaneously from a variety of patients
and examined by sheep cell agglutination or latex fixation tests, pre- and
post-hyaluronidase treatment.
Group A: Twenty pairs from patients with rheumatic disease (sheep
cell agglutination test*-Ball.'
Group B: Ten joint fluids obtained post mortem from patients with no
known rheumatic disease (sheep cell agglutination test*-Ball.6
Group C: Forty-three pairs obtained from patients with a variety of
rheumatic diseases (latex fixation test).'
2. No significant changes in titer occurred in Group A tests following
hyaluronidase digestion; no changes at all occurred in Groups B and C.
The evidence is that rheumatoid factor, though present in joint fluid
of patients with rheumatoid arthritis, is not chemically combined with
hyaluronic acid. Incubation of sera and joint fluids with hyaluronidase
does not significantly alter the results of the sheep cell agglutination or
latex fixation tests.
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